Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KNC Laboratories CoTSE:6568 -1.12%81 EV-to-EBITDA is 4.38 as of Sep. 02, 2026, which is 57% below its 10-year median of 10.26. GuruFocus rates TSE:6568 with a GF Score™ of 81/100 and a GF Value™ of 円1,297.20 (Fairly Valued). The stock has 5 warning signs investors should review. Among 1,340 Chemicals companies, KNC Laboratories Co ranks better than 88.36% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, KNC Laboratories Co's enterprise value is 円10,397 Mil.
KNC Laboratories Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was 円2,373 Mil. Therefore, KNC Laboratories Co's EV-to-EBITDA for today is 4.38.
The historical rank and industry rank for KNC Laboratories Co's EV-to-EBITDA or its related term are showing as below:
TSE:6568'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.06 Med: 10.26 Max: 267.62
Current: 4.38
During the past 11 years, the highest EV-to-EBITDA of KNC Laboratories Co was 267.62. The lowest was 4.06. And the median was 10.26.
TSE:6568's EV-to-EBITDA is ranked better than 88.36% of 1340
companies
in the Chemicals industry
Industry Median: 12.38
vs TSE:6568: 4.38
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
KNC Laboratories Co (TSE:6568) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
KNC Laboratories Co's PE Ratio (TTM) for today is calculated as:
KNC Laboratories Co's share price for today is 円1231.00.
KNC Laboratories Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円105.780.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for KNC Laboratories Co's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, KNC Laboratories Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KNC Laboratories Co EV-to-EBITDA vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, KNC Laboratories Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where KNC Laboratories Co's EV-to-EBITDA falls into.
KNC Laboratories Co's current Enterprise Value is 円10,397 Mil.
KNC Laboratories Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円2,373 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KNC Laboratories Co (TSE:6568) has a EV-to-EBITDA of 4.38 as of Sep. 02, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on KNC Laboratories Co. This is 57% below median its historical median of 10.26. Over the past decade, KNC Laboratories Co's EV-to-EBITDA has ranged from 4.06 to 267.62. According to the industry distribution chart, KNC Laboratories Co ranks #156 out of 1340 companies in the Chemicals industry, placing it in the top 11.6%.
Is KNC Laboratories Co's EV-to-EBITDA too high?
KNC Laboratories Co's current EV-to-EBITDA of 4.38 is 57% below median its 10-year median of 10.26. Over the past 10 years, this metric has ranged from a low of 4.06 to a high of 267.62. The Chemicals industry median EV-to-EBITDA is 12.38. KNC Laboratories Co's value of 4.38 is 64.6% below this industry median. Based on the distribution chart, KNC Laboratories Co ranks #156 out of 1340 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, KNC Laboratories Co has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does KNC Laboratories Co's EV-to-EBITDA compare to DOW?
According to the Chemicals industry distribution chart, KNC Laboratories Co ranks #156 out of 1340 companies for EV-to-EBITDA. This places KNC Laboratories Co in the top 12% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 12.38. KNC Laboratories Co's value of 4.38 is 64.6% below this benchmark. Historically, KNC Laboratories Co's own EV-to-EBITDA has ranged from 4.06 to 267.62 over the past decade. While the company's 10-year median is 10.26 vs. the industry median of 12.38, KNC Laboratories Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Chemicals company?
The median EV-to-EBITDA among Chemicals companies is 12.38, based on 1,340 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KNC Laboratories Co's current EV-to-EBITDA of 4.38 is 64.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on KNC Laboratories Co. For the Chemicals industry, the median EV-to-EBITDA is 12.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KNC Laboratories Co's current EV-to-EBITDA is 4.38, which is 57% below median its own 10-year median of 10.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KNC Laboratories Co stock overvalued right now?
Based on GuruFocus' analysis, KNC Laboratories Co (TSE:6568) is currently considered Fairly Valued. The stock's GF Value™ is 円1,297.20, compared to a current price of 円1,231.00 — trading 5.1% below its estimated fair value. The current EV-to-EBITDA is 4.38, which is 57% below median its 10-year median of 10.26 and 64.6% below the Chemicals industry median of 12.38. KNC Laboratories Co's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For KNC Laboratories Co (TSE:6568), the current EV-to-EBITDA is 4.38 as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KNC Laboratories Co (TSE:6568) Overvalued in 2026?
Based on GuruFocus' analysis, KNC Laboratories Co stock appears to be undervalued.
The current stock price of 円1,231.00 is trading 5.1% below its estimated GF Value™ of 円1,297.20.
GuruFocus considers KNC Laboratories Co to be Fairly Valued.
Key valuation signals for TSE:6568:
EV-to-EBITDA: 4.38 (57% below median its 10-year median of 10.26)
GF Value™: 円1,297.20 vs. price of 円1,231.00 (5.1% below fair value)
Industry Position: 64.6% below the Chemicals median (#156 of 1340)
No single metric tells the full story. See the TSE:6568 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6568 has been successfully added to your 
